Fragile X syndrome: Prevalence, treatment, and prevention in China

Manman Niu, Ying Han, Angel Belle C. Dy, Junbao Du, Hongfang Jin, Jiong Qin, Jing Zhang, Qinrui Li, Randi J Hagerman

Research output: Contribution to journalReview article

Abstract

Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and the leading monogenic cause of autism spectrum disorder. Although FXS has been studied for several decades, there is relatively little basic science or clinical research being performed on FXS in China. Indeed, there is a large gap between China and Western countries in the FXS field. China has a potentially large number of FXS patients. However, many of them are underdiagnosed or even misdiagnosed, and treatments are not always administered in the Chinese population. This review discusses the prevalence, treatment, and prevention of FXS in China to facilitate an understanding of this disease in the Chinese population.

Original languageEnglish (US)
Article number254
JournalFrontiers in Neurology
Volume8
Issue numberJUN
DOIs
StatePublished - Jun 6 2017

Fingerprint

Fragile X Syndrome
China
Therapeutics
Diagnostic Errors
Intellectual Disability
Population
Research

Keywords

  • China
  • Fragile X syndrome
  • Prevalence
  • Prevention
  • Treatment

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Fragile X syndrome : Prevalence, treatment, and prevention in China. / Niu, Manman; Han, Ying; Dy, Angel Belle C.; Du, Junbao; Jin, Hongfang; Qin, Jiong; Zhang, Jing; Li, Qinrui; Hagerman, Randi J.

In: Frontiers in Neurology, Vol. 8, No. JUN, 254, 06.06.2017.

Research output: Contribution to journalReview article

Niu, M, Han, Y, Dy, ABC, Du, J, Jin, H, Qin, J, Zhang, J, Li, Q & Hagerman, RJ 2017, 'Fragile X syndrome: Prevalence, treatment, and prevention in China', Frontiers in Neurology, vol. 8, no. JUN, 254. https://doi.org/10.3389/fneur.2017.00254
Niu, Manman ; Han, Ying ; Dy, Angel Belle C. ; Du, Junbao ; Jin, Hongfang ; Qin, Jiong ; Zhang, Jing ; Li, Qinrui ; Hagerman, Randi J. / Fragile X syndrome : Prevalence, treatment, and prevention in China. In: Frontiers in Neurology. 2017 ; Vol. 8, No. JUN.
@article{02e73f4c3700417f8a03357f18e56dcb,
title = "Fragile X syndrome: Prevalence, treatment, and prevention in China",
abstract = "Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and the leading monogenic cause of autism spectrum disorder. Although FXS has been studied for several decades, there is relatively little basic science or clinical research being performed on FXS in China. Indeed, there is a large gap between China and Western countries in the FXS field. China has a potentially large number of FXS patients. However, many of them are underdiagnosed or even misdiagnosed, and treatments are not always administered in the Chinese population. This review discusses the prevalence, treatment, and prevention of FXS in China to facilitate an understanding of this disease in the Chinese population.",
keywords = "China, Fragile X syndrome, Prevalence, Prevention, Treatment",
author = "Manman Niu and Ying Han and Dy, {Angel Belle C.} and Junbao Du and Hongfang Jin and Jiong Qin and Jing Zhang and Qinrui Li and Hagerman, {Randi J}",
year = "2017",
month = "6",
day = "6",
doi = "10.3389/fneur.2017.00254",
language = "English (US)",
volume = "8",
journal = "Frontiers in Neurology",
issn = "1664-2295",
publisher = "Frontiers Research Foundation",
number = "JUN",

}

TY - JOUR

T1 - Fragile X syndrome

T2 - Prevalence, treatment, and prevention in China

AU - Niu, Manman

AU - Han, Ying

AU - Dy, Angel Belle C.

AU - Du, Junbao

AU - Jin, Hongfang

AU - Qin, Jiong

AU - Zhang, Jing

AU - Li, Qinrui

AU - Hagerman, Randi J

PY - 2017/6/6

Y1 - 2017/6/6

N2 - Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and the leading monogenic cause of autism spectrum disorder. Although FXS has been studied for several decades, there is relatively little basic science or clinical research being performed on FXS in China. Indeed, there is a large gap between China and Western countries in the FXS field. China has a potentially large number of FXS patients. However, many of them are underdiagnosed or even misdiagnosed, and treatments are not always administered in the Chinese population. This review discusses the prevalence, treatment, and prevention of FXS in China to facilitate an understanding of this disease in the Chinese population.

AB - Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability and the leading monogenic cause of autism spectrum disorder. Although FXS has been studied for several decades, there is relatively little basic science or clinical research being performed on FXS in China. Indeed, there is a large gap between China and Western countries in the FXS field. China has a potentially large number of FXS patients. However, many of them are underdiagnosed or even misdiagnosed, and treatments are not always administered in the Chinese population. This review discusses the prevalence, treatment, and prevention of FXS in China to facilitate an understanding of this disease in the Chinese population.

KW - China

KW - Fragile X syndrome

KW - Prevalence

KW - Prevention

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=85020734038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020734038&partnerID=8YFLogxK

U2 - 10.3389/fneur.2017.00254

DO - 10.3389/fneur.2017.00254

M3 - Review article

AN - SCOPUS:85020734038

VL - 8

JO - Frontiers in Neurology

JF - Frontiers in Neurology

SN - 1664-2295

IS - JUN

M1 - 254

ER -